Skip to main content

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top

Open Access 27-02-2025 | Letter to the Editor

Enhancing heart failure detection and patient engagement with the Maastricht Decompensation Questionnaire

Auteurs: Arno J. Gingele, Hans-Peter Brunner-La Rocca

Gepubliceerd in: Netherlands Heart Journal

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN
Opmerkingen
The work was performed at the Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Dear Editor,
Recently, we published the results of the Maastricht Decompensation Questionnaire (MDQ) trial, demonstrating that the MDQ effectively identifies decompensated heart failure (HF) patients using patient-reported signs and symptoms [1]. We appreciate the insightful commentary by Fiolet and Szymanski on our article [2].
They raised concerns about the use of HF nurses’ fluid status assessments as the reference standard. However, as the MDQ was administered during routine ambulatory evaluations, HF nurses had access to complementary data, including biochemical markers and regularly echocardiography, collected routinely as indicated. Thus, our standard was not solely based on physical examination.
While adding objective parameters may further improve risk prediction models, clinical practice often relies on history-taking, especially in remote consultations. The MDQ was designed to reflect this reality, and our study confirms its effectiveness.
To further improve its diagnostic accuracy, we are personalising the MDQ to align with individual patient profiles, enhancing sensitivity and specificity. Additionally, we are integrating features such as avatars and chatbots to improve patient engagement [3]. These innovations will be prospectively tested in a large cohort of HF patients.

Funding

This work received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of Interest

A.J. Gingele declares that he has no competing interests. H.-P. Brunner-La Rocca received grants from Vifor, Roche Diagnostics and IHI (iCARE4CVD) and is a member of the Committee Medication of Dutch Society of Cardiology; he received consulting fees from Novartis, Roche Diagnostics, Boehringer-Ingelheim, AstraZeneca, Novo Nordisk, and Vifor; he received payments for expert testimony from Novartis.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

Netherlands Heart Journal

Het Netherlands Heart Journal wordt uitgegeven in samenwerking met de Nederlandse Vereniging voor Cardiologie. Het tijdschrift is Engelstalig en wordt gratis beschikbaa ...

Literatuur
1.
go back to reference Gingele AJ, Beckers F, Boyne JJ, Brunner-La RHP. Fluid status assessment in heart failure patients: pilot validation of the Maastricht Decompensation Questionnaire. Neth Heart J. 2025;33:7–13.CrossRefPubMed Gingele AJ, Beckers F, Boyne JJ, Brunner-La RHP. Fluid status assessment in heart failure patients: pilot validation of the Maastricht Decompensation Questionnaire. Neth Heart J. 2025;33:7–13.CrossRefPubMed
2.
go back to reference Fiolet ATL, Szymanski MK. Chances and challenges of questionnaires in heart failure care. Neth Heart J. 2025;33:5–6.CrossRefPubMed Fiolet ATL, Szymanski MK. Chances and challenges of questionnaires in heart failure care. Neth Heart J. 2025;33:5–6.CrossRefPubMed
3.
go back to reference Gingele AJ, Amin H, Vaassen A, et al. Integrating avatar technology into a telemedicine application in heart failure patients : A pilot study. Wien Klin Wochenschr. 2023;135:680–4.CrossRefPubMedPubMedCentral Gingele AJ, Amin H, Vaassen A, et al. Integrating avatar technology into a telemedicine application in heart failure patients : A pilot study. Wien Klin Wochenschr. 2023;135:680–4.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Enhancing heart failure detection and patient engagement with the Maastricht Decompensation Questionnaire
Auteurs
Arno J. Gingele
Hans-Peter Brunner-La Rocca
Publicatiedatum
27-02-2025
Uitgeverij
BSL Media & Learning
Gepubliceerd in
Netherlands Heart Journal
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-025-01945-4